Core Viewpoint - Dogecoin Cash Inc. has established a new subsidiary, Dogecoin Treasury, Inc. (DTI), to develop and manage software tools and infrastructure related to Dogecoin, including the ongoing development of the Dogecoin Protocol [1][2][3] Company Overview - Dogecoin Cash, Inc. (OTCQB: DOGP) is a publicly traded company involved in digital asset development and operates PrestoDoctor, a leader in medical cannabis telemedicine [4] - The company holds the first patented cannabis strain and a patented cannabis lozenge for hypertension treatment, focusing on cannabis product development and licensing [4][5] Business Segments - The core business segments include cannabis telemedicine and the development of cannabis-based products, with an emphasis on expanding the product portfolio through strategic licensing and partnerships [5] - The company is exploring blockchain technology and decentralized finance (DeFi) applications to enhance transparency and efficiency in cannabis supply chains [6] Strategic Initiatives - Dogecoin Cash, Inc. is actively pursuing strategic mergers, acquisitions, and joint ventures to strengthen its position in both the cannabis and blockchain sectors [7] - The company aims to broaden its investor base and enhance shareholder value through market expansion and diversification of revenue streams [8] Future Vision - The long-term vision of Dogecoin Cash, Inc. includes leveraging blockchain for real-world applications, such as traceability in the cannabis industry and DeFi lending solutions [9]
Dogecoin Cash Inc. (OTCQB: DOGP) Forms Dogecoin Treasury, Inc. to Support Development of Dogecoin-Related Tools and Infrastructure
Globenewswire·2025-07-01 14:53